Sign In
Buy BBH
$181.73
-4.21 (-2.26%)
At Close: Jun 02, 2026
Top ETF Stories of November
02:33pm, Wednesday, 01'st Dec 2021
The emergence of the Omicron variant of Covid-19 and inflationary pressure were key highlights of the broader market in November.
Moderna ETFs Rallying on COVID-19 Vaccine News to Combat Omicron
05:57pm, Tuesday, 30'th Nov 2021 Zacks Investment Research
Moderna has been rallying amid concerns surrounding the omicron variant, which has led to possibilities of a rise in demand for COVID-19 vaccines and boosters.
BBH: Better Than IBB For Covid Exposure Including The Omicron Variant
02:25pm, Tuesday, 30'th Nov 2021
The relatively less known VanEck's BBH has delivered a better one-year performance than the popular iShares' IBB.
ETF Areas to Gain/Lose on Fear of Omicron Strain of Coronavirus
06:00pm, Monday, 29'th Nov 2021 Zacks Investment Research
The emergence of a new coronavirus strain, namely Omicron, has caused a massacre on Wall Street on Friday. These ETFs could gain/lose in the coming days if Omicron cases continue to rise.
ETF Areas to Gain/Lose on Fear of Omicron Strain of Coronavirus
02:36pm, Monday, 29'th Nov 2021
The emergence of a new coronavirus strain, namely Omicron, has caused a massacre on Wall Street on Friday. These ETFs could gain/lose in the coming days if Omicron cases continue to rise.
VanEck Vectors Biotech ETF (NASDAQ:BBH) Shares Gap Up to $192.41
05:14pm, Friday, 26'th Nov 2021 Dakota Financial News
VanEck Vectors Biotech ETF (NASDAQ:BBH)s share price gapped up before the market opened on Friday . The stock had previously closed at $192.41, but opened at $198.91. VanEck Vectors Biotech ETF shares last traded at $198.91, with a volume of 100 shares. The firms 50-day moving average price is $197.80 and its two-hundred day moving []
Morgan Stanley Has $12.67 Million Stock Position in VanEck Vectors Biotech ETF (NASDAQ:BBH)
09:58am, Thursday, 25'th Nov 2021 Dakota Financial News
Morgan Stanley decreased its position in VanEck Vectors Biotech ETF (NASDAQ:BBH) by 1.8% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 62,810 shares of the companys stock after selling 1,125 shares during the period. Morgan Stanley owned approximately 2.21% of VanEck Vectors Biotech ETF []
Biotech ETFs
07:29pm, Monday, 22'nd Nov 2021 The Motley Fool
Here are the five best biotech ETFs to invest in right now.
Moderna ETFs to Rally on Positive COVID-19 Booster Shot News
07:14pm, Monday, 22'nd Nov 2021 Zacks Investment Research
Moderna is expected to gain approval for booster shots for its COVID-19 vaccine.
With Amgen Shares Trending Lower, 3 Trades To Take Advantage Of The Dip
02:04pm, Monday, 15'th Nov 2021 Investing.comShould You Invest in the VanEck Biotech ETF (BBH)?
07:43am, Monday, 08'th Nov 2021
Sector ETF report for BBH
How Are Biotech ETFs Reacting to These Q3 Earnings Releases?
12:50am, Saturday, 06'th Nov 2021
Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.
Can Biotech ETFs Gain From Positive Booster Update?
05:24pm, Thursday, 21'st Oct 2021
In an effort to combat the coronavirus outbreak and accelerate the distribution process of extra doses in the United States, the FDA has approved the vaccine booster shots.
Take a Look at the Top-Performing Biotech ETFs YTD
09:25am, Saturday, 02'nd Oct 2021
The pandemic has triggered a race to introduce vaccines and treatment options, opening up investment opportunities in the biotech sector.
BBH: This ETF Provides Robust Returns To Investors In The Biotech Sector
05:01am, Sunday, 26'th Sep 2021
VanEck Vectors Biotech ETF is a biotech centric ETF with passive investment approach. The fund invests in a small number of biotech companies.
